Sponsor Pipeline

MavriX Bio, LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT07181837
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome		 overall status: Active, Not Recruiting → Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07181837 A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome Angelman Syndrome Recruiting
Get alerts when MavriX Bio, LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free